NCT06113965

Brief Summary

The goal of this clinical trial is to learn if operant conditioning can reduce spasticity in order to improve walking in stroke patient. The main questions it aims to answer are:

  • Can participants self-regulate reflex excitability
  • Can participants self-regulate reflex, reduce spasticity and improve walking Participants will undergo surface stimulation to evoke spinal reflexes and will be asked to control these reflexes therefore reducing spasticity. Researchers will compare result to able bodied participants to see if \[insert effects\]

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
26mo left

Started Dec 2024

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Dec 2024May 2028

First Submitted

Initial submission to the registry

October 23, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 31, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

March 10, 2025

Status Verified

January 1, 2025

Enrollment Period

2.4 years

First QC Date

October 23, 2023

Last Update Submit

March 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Surface electromyographic recording of leg muscles

    Recording electrical activity of leg muscles during walking in response to peripheral nerve stimulation

    baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment

Secondary Outcomes (4)

  • 10 meter walk test

    baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment

  • quadriceps pendulum test

    baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment

  • Five Times Sit to Stand Test

    baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment

  • Transcranial Magnetic Stimulation (TMS)

    Baseline, Week 12 - end of treatment

Study Arms (1)

Experimental: Post-stroke Stiff-Knee Gait Participants

EXPERIMENTAL

Individuals with post-stroke Stiff-Knee gait

Device: Peripheral Nerve Stimulation

Interventions

Electrical stimulation of peripheral nerves to measure resulting gait kinematics and surface muscle activity

Experimental: Post-stroke Stiff-Knee Gait Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sign and date consent form
  • At least 3 months since stroke event
  • Over 18 years of age at time of eligibility
  • Ability to stand upright and walk for at least 5 minutes
  • Premorbidly independent
  • Mild to moderate gait impairment
  • Reduced knee flexion during walking relative to the unimpaired side
  • Unilateral hemiparesis of the lower limbs
  • Ability to evoke muscle responses through peripheral nerve stimulation, spinal cord stimulation, and transcranial magnetic stimulation
  • Medically stable
  • Skin intact on hemiparetic leg, abdomen, and scalp
  • Ability to evoke muscle responses and/or reflex responses through peripheral nerve stimulation, spinal cord stimulation, and/or transcranial magnetic stimulation

You may not qualify if:

  • Co-existing neurological condition other than prior stroke involving the hemiparetic lower limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).
  • History of lower limb musculoskeletal injury
  • Functionally relevant osteoarthritis and weight bearing restriction
  • Functionally relevant polyneuropathy resulting in lack of sensation in the lower leg
  • Functionally relevant cognitive impairment
  • Functionally relevant vision impairment
  • Pregnant
  • Botox injection to the ipsilateral leg in the last 12 weeks or taking oral anti-spasticity medications
  • Taking part in physical therapy for any walking-related impairment
  • Cardiac pacemaker or other implanted electronic systems
  • Uncontrolled seizure disorder
  • Use of seizure lowering threshold medications and the discretion of the study physician
  • Deficits in communication that interfere with reasonable study participation
  • Severely impaired cognition and communication
  • Severe lower limb pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MetroHealth Medical Center

Cleveland, Ohio, 44109, United States

Location

Related Publications (11)

  • Burpee JL, Lewek MD. Biomechanical gait characteristics of naturally occurring unsuccessful foot clearance during swing in individuals with chronic stroke. Clin Biomech (Bristol). 2015 Dec;30(10):1102-7. doi: 10.1016/j.clinbiomech.2015.08.018. Epub 2015 Sep 2.

    PMID: 26371855BACKGROUND
  • Akbas T, Kim K, Doyle K, Manella K, Lee R, Spicer P, Knikou M, Sulzer J. Rectus femoris hyperreflexia contributes to Stiff-Knee gait after stroke. J Neuroeng Rehabil. 2020 Aug 26;17(1):117. doi: 10.1186/s12984-020-00724-z.

    PMID: 32843057BACKGROUND
  • Li S, Francisco GE. New insights into the pathophysiology of post-stroke spasticity. Front Hum Neurosci. 2015 Apr 10;9:192. doi: 10.3389/fnhum.2015.00192. eCollection 2015.

    PMID: 25914638BACKGROUND
  • Li S, Francisco GE, Zhou P. Post-stroke Hemiplegic Gait: New Perspective and Insights. Front Physiol. 2018 Aug 2;9:1021. doi: 10.3389/fphys.2018.01021. eCollection 2018.

    PMID: 30127749BACKGROUND
  • Stoquart GG, Detrembleur C, Palumbo S, Deltombe T, Lejeune TM. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study. Arch Phys Med Rehabil. 2008 Jan;89(1):56-61. doi: 10.1016/j.apmr.2007.08.131.

    PMID: 18164331BACKGROUND
  • Dehnadi Moghadam A, Hasanzadeh H, Dehnadi Moghadam F. Evaluation of the Effect of Intranasal Lidocaine in the Treatment of Spasticity in Patients with Traumatic Brain Injury. Anesth Pain Med. 2021 Aug 15;11(4):e115849. doi: 10.5812/aapm.115849. eCollection 2021 Aug.

    PMID: 34692437BACKGROUND
  • Navarrete-Opazo AA, Gonzalez W, Nahuelhual P. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy. Arch Phys Med Rehabil. 2016 Apr;97(4):604-618. doi: 10.1016/j.apmr.2015.08.417. Epub 2015 Aug 28.

    PMID: 26321489BACKGROUND
  • Wolpaw JR, Braitman DJ, Seegal RF. Adaptive plasticity in primate spinal stretch reflex: initial development. J Neurophysiol. 1983 Dec;50(6):1296-311. doi: 10.1152/jn.1983.50.6.1296.

    PMID: 6663327BACKGROUND
  • Wolpaw JR, Lee CL. Motoneuron response to dorsal root stimulation in anesthetized monkeys after spinal cord transection. Exp Brain Res. 1987;68(2):428-33. doi: 10.1007/BF00248809.

    PMID: 3480233BACKGROUND
  • Chen XY, Wolpaw JR. Operant conditioning of H-reflex in freely moving rats. J Neurophysiol. 1995 Jan;73(1):411-5. doi: 10.1152/jn.1995.73.1.411.

    PMID: 7714584BACKGROUND
  • Thompson AK, Chen XY, Wolpaw JR. Acquisition of a simple motor skill: task-dependent adaptation plus long-term change in the human soleus H-reflex. J Neurosci. 2009 May 6;29(18):5784-92. doi: 10.1523/JNEUROSCI.4326-08.2009.

    PMID: 19420246BACKGROUND

MeSH Terms

Conditions

StrokeGait Disorders, NeurologicMobility Limitation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • James Sulzer, PhD

    MetroHealth Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
James Sulzer, PhD

Study Record Dates

First Submitted

October 23, 2023

First Posted

November 2, 2023

Study Start

December 31, 2024

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2028

Last Updated

March 10, 2025

Record last verified: 2025-01

Locations